A Retrospective Observational Study of Domiciliary Oxygen Usage in a Subset of Veterans

References

1. 1.↵
   Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93(3):391-398.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;I(8222):681-686.
3. 3.↵
   1. Borak J,
   2. Sliwiński P,
   3. Tobiasz M,
   4. Górecka D,
   5. Zieliński J

   . Psychological status of COPD patients before and after one year of long-term oxygen therapy. Monaldi Arch Chest Dis 1996;51(1):7-11.

   OpenUrlPubMed
4. 4.
   1. Eaton T,
   2. Lewis C,
   3. Young P,
   4. Kennedy Y,
   5. Garrett JE,
   6. Kolbe J

   . Long-term oxygen therapy improves health-related quality of life. Respir Med 2004;98(4):285-293.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Petty TL

   . Home oxygen–a revolution in the care of advanced COPD. Med Clin North Am 1990;74(3):715-729.

   OpenUrlPubMed
6. 6.↵
   1. Ringbaek TJ,
   2. Viskum K,
   3. Lange P

   . Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Eur Respir J 2002;20(1):38-42.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Bell EC,
   2. Cox NS,
   3. Goh N,
   4. Glaspole I,
   5. Westall GP,
   6. Watson A,
   7. Holland AE

   . Oxygen therapy for interstitial lung disease: a systematic review. Eur Respir Rev 2017;26(143). pii: 160080

   OpenUrl
8. 8.↵
   1. Hardinge M,
   2. Annandale J,
   3. Bourne S,
   4. Cooper B,
   5. Evans A,
   6. Freeman D,
   7. et al

   ; British Thotacic Society Home Oxygen Guideline Development Group; British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for home oxygen use in adults. Thorax 2015;70(Suppl 1):i1-i43.

   OpenUrl
9. 9.↵
   1. Crockett AJ,
   2. Cranston JM,
   3. Antic N

   . Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst Rev 2001(3):CD002883.
10. 10.
    1. Crockett AJ,
    2. Alpers JH,
    3. Moss JR

    . Home oxygen therapy: an audit of survival. Aust N Z J Med 1991;21(2):217-221.

    OpenUrlPubMed
11. 11.
    1. Campbell AJ,
    2. Ferrier K,
    3. Neill AM

    . Effect of oxygen versus adaptive pressure support servo-ventilation in patients with central sleep apnoea-Cheyne Stokes respiration and congestive heart failure. Intern Med J 2012;42(10):1130-1136.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Ström K,
    2. Boman G

    . Long-term oxygen therapy in parenchymal lung diseases: an analysis of survival. The Swedish Society of Chest Medicine. Eur Respir J 1993;6(9):1264-1270.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Ulrich S,
    2. Saxer S,
    3. Hasler ED,
    4. Schwarz EI,
    5. Schneider SR,
    6. Furian M,
    7. et al

    . Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial. Eur Respir J 2019;54(2). pii: 1900276.

    OpenUrl
14. 14.↵
    1. Albert RK,
    2. Au DH,
    3. Blackford AL,
    4. Casaburi R,
    5. Cooper JA Jr.,
    6. et al

    Long-Term Oxygen Treatment Trial Research G, Albert RK, Au DH, Blackford AL, Casaburi R, Cooper JA Jr., et al. A randomized trial of long-term oxygen for COPD with moderate desaturation. N Engl J Med 2016;375(17):1617-1627.

    OpenUrlCrossRefPubMed
15. 15.↵
    U.S. Department of Health and Human Services. Centers for Medicare & Medicaid Services. Office of Research Development and Information. 2016 CMS statistics. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/CMS-Statistics-Reference-Booklet/Downloads/2016_CMS_Stats.pdf. Accessed on May 9, 2019.
16. 16.↵
    1. Yu WC,
    2. Fu SN,
    3. Tai EL,
    4. Yeung YC,
    5. Kwong KC,
    6. Chang Y,
    7. et al

    . Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis 2013;8:389-395.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Nishi SP,
    2. Wang Y,
    3. Kuo YF,
    4. Goodwin JS,
    5. Sharma G

    . Spirometry use among older adults with chronic obstructive pulmonary disease: 1999–2008. Ann Am Thorac Soc 2013;10(6):565-573.

    OpenUrl
18. 18.↵
    1. Miravitlles M,
    2. de la Roza C,
    3. Naberan K,
    4. Lamban M,
    5. Gobartt E,
    6. Martin A

    . Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med 2007;101(8):1753-1760.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Joo MJ,
    2. Au DH,
    3. Fitzgibbon ML,
    4. McKell J,
    5. Lee TA

    . Determinants of spirometry use and accuracy of COPD diagnosis in primary care. J Gen Intern Med 2011;26(11):1272-1277.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Sator L,
    2. Horner A,
    3. Studnicka M,
    4. Lamprecht B,
    5. Kaiser B,
    6. McBurnie MA,
    7. et al

    . Overdiagnosis of COPD in subjects with unobstructed spirometry: a BOLD Analysis. Chest 2019;156(2):277-288.

    OpenUrl
21. 21.↵
    1. Ringbaek TJ,
    2. Lange P,
    3. Viskum K

    . Geographic variation in long-term oxygen therapy in Denmark: factors related to adherence to guidelines for long-term oxygen therapy. Chest 2001;119(6):1711-1716.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Stolz D,
    2. Boersma W,
    3. Blasi F,
    4. Louis R,
    5. Milenkovic B,
    6. Kostikas K,
    7. et al

    . Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. Chest 2014;146(2):328-338.

    OpenUrl
23. 23.↵
    1. Andrianopoulos V,
    2. Franssen FM,
    3. Peeters JP,
    4. Ubachs TJ,
    5. Bukari H,
    6. Groenen M,
    7. et al

    . Exercise-induced oxygen desaturation in COPD patients without resting hypoxemia. Respir Physiol Neurobiol 2014;190:40-46.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Ahmadi Z,
    2. Sundh J,
    3. Bornefalk-Hermansson A,
    4. Ekström M

    . Long-term oxygen therapy 24 vs 15 h/day and mortality in chronic obstructive pulmonary disease. PLoS One 2016;11(9):e0163293.

    OpenUrl
25. 25.↵
    1. Fletcher EC,
    2. Luckett RA,
    3. Goodnight-White S,
    4. Miller CC,
    5. Qian W,
    6. Costarangos-Galarza C

    . A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis 1992;145(5):1070-1076.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Lacasse Y,
    2. Bernard S,
    3. Series F,
    4. Nguyen VH,
    5. Bourbeau J,
    6. Aaron S,
    7. et al

    ; International Nocturnal Oxygen (INOX) Research Group. Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial. BMC Pulm Med 2017;17(1):8.

    OpenUrl
27. 27.↵
    1. Wu H,
    2. Wise RA,
    3. Medinger AE

    . Do patients hospitalized with COPD have airflow obstruction? Chest 2017;151(6):1263-1271.

    OpenUrl
28. 28.↵
    1. Visca D,
    2. Mori L,
    3. Tsipouri V,
    4. Fleming S,
    5. Firouzi A,
    6. Bonini M,
    7. et al

    . Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir Med 2018;6(10):759-770.

    OpenUrl